Man Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.4M | Sell |
34,669
-44,980
| -56% | -$13.8M | 0.02% | 681 |
|
|
2026
Q1 | $20M | Buy |
79,649
+12,321
| +18% | +$3.07M | 0.04% | 501 |
|
|
2025
Q4 | $18.5M | Sell |
67,328
-35,157
| -34% | -$9.62M | 0.03% | 544 |
|
|
2025
Q3 | $26.9M | Buy |
102,485
+2,507
| +3% | +$609K | 0.05% | 413 |
|
|
2025
Q2 | $21.9M | Buy |
99,978
+69,069
| +223% | +$14.8M | 0.04% | 481 |
|
|
2025
Q1 | $6.92M | Buy |
30,909
+14,547
| +89% | +$4.01M | 0.02% | 883 |
|
|
2024
Q4 | $5.36M | Sell |
16,362
-7,046
| -30% | -$2.22M | 0.01% | 987 |
|
|
2024
Q3 | $7.03M | Sell |
23,408
-180,847
| -89% | -$55.4M | 0.02% | 898 |
|
|
2024
Q2 | $67.3M | Buy |
204,255
+178,428
| +691% | +$63.1M | 0.17% | 136 |
|
|
2024
Q1 | $10.2M | Sell |
25,827
-123,831
| -83% | -$45.8M | 0.03% | 689 |
|
|
2023
Q4 | $52.7M | Buy |
+149,658
| New | +$53M | 0.15% | 159 |
|
|
2023
Q3 | – | Sell |
-251,465
| Closed | -$97.2M | – | 74 |
|
|
2023
Q2 | $96.2M | Buy |
+251,465
| New | +$89.8M | 0.3% | 62 |
|
|
2023
Q1 | – | Sell |
-54,877
| Closed | -$16M | – | 246 |
|
|
2022
Q4 | $12.9M | Sell |
54,877
-23,486
| -30% | -$5.57M | 0.05% | 471 |
|
|
2022
Q3 | $19.3M | Buy |
+78,363
| New | +$23.9M | 0.09% | 262 |
|
|
2022
Q2 | – | Sell |
-206,773
| Closed | -$67.3M | – | 66 |
|
|
2022
Q1 | $84.9M | Buy |
206,773
+35,092
| +20% | +$13.7M | 0.3% | 69 |
|
|
2021
Q4 | $80.5M | Buy |
171,681
+130,413
| +316% | +$56.1M | 0.26% | 79 |
|
|
2021
Q3 | $17.5M | Buy |
41,268
+15,759
| +62% | +$6.64M | 0.06% | 378 |
|
|
2021
Q2 | $9.16M | Sell |
25,509
-161
| -0.6% | -$53.2K | 0.03% | 617 |
|
|
2021
Q1 | $7.23M | Buy |
25,670
+3,239
| +14% | +$927K | 0.03% | 545 |
|
|
2020
Q4 | $6.36M | Sell |
22,431
-31,923
| -59% | -$8.96M | 0.03% | 663 |
|
|
2020
Q3 | $14.9M | Buy |
54,354
+8,739
| +19% | +$2.31M | 0.06% | 348 |
|
|
2020
Q2 | $10.4M | Sell |
45,615
-19,411
| -30% | -$3.81M | 0.05% | 353 |
|
|
2020
Q1 | $9.9M | Buy |
65,026
+2,656
| +4% | +$409K | 0.06% | 294 |
|
|
2019
Q4 | $9.38M | Buy |
62,370
+15,300
| +33% | +$2.23M | 0.03% | 720 |
|
|
2019
Q3 | $6.67M | Sell |
47,070
-30,454
| -39% | -$4.19M | 0.02% | 741 |
|
|
2019
Q2 | $9.7M | Buy |
77,524
+23,604
| +44% | +$2.79M | 0.04% | 646 |
|
|
2019
Q1 | $5.94M | Buy |
53,920
+6,343
| +13% | +$660K | 0.02% | 822 |
|
|
2018
Q4 | $4.66M | Sell |
47,577
-74,725
| -61% | -$8.11M | 0.02% | 805 |
|
|
2018
Q3 | $15.1M | Buy |
122,302
+9,501
| +8% | +$1.07M | 0.06% | 435 |
|
|
2018
Q2 | $11.2M | Buy |
112,801
+56,133
| +99% | +$5.17M | 0.05% | 526 |
|
|
2018
Q1 | $5M | Buy |
+56,668
| New | +$5.3M | 0.02% | 845 |
|
Other funds holding WST
GIM
Man Group's WST Position: Q2 2026 in Review
Man Group reduced its West Pharmaceutical (WST) stake by 56% in Q2 2026, selling an estimated $13.8M and leaving 34,669 shares worth $12.4M. The position accounts for 0.02% of the portfolio, ranked #681.
Man Group first reported a position in WST in Q1 2018 and has held it in 31 quarters since. The position peaked at $96.2M in Q2 2023. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Man Group held 34,669 shares of West Pharmaceutical worth $12.4M as of Q2 2026.
- Man Group sold 44,980 West Pharmaceutical shares in Q2 2026, an estimated $13.8M.
- West Pharmaceutical made up 0.02% of Man Group's portfolio in Q2 2026, its #681 holding.
- Man Group first reported a position in West Pharmaceutical in Q1 2018 and has held it in 31 quarters since.
- Man Group's West Pharmaceutical position peaked at $96.2M in Q2 2023.
- 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.